These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6141721)

  • 1. Selective alpha 1-adrenergic antagonists: therapeutically relevant antihypertensive agents.
    Graham RM
    Am J Cardiol; 1984 Jan; 53(3):16A-20A. PubMed ID: 6141721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension.
    Warren JB; Dollery CT
    J Hypertens Suppl; 1988 Dec; 6(2):S43-9. PubMed ID: 2906700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance.
    Cubeddu LX
    Am Heart J; 1988 Jul; 116(1 Pt 1):133-62. PubMed ID: 2899387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
    Colucci WS
    Ann Intern Med; 1982 Jul; 97(1):67-77. PubMed ID: 6124197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology and therapeutic role of prazosin and related alpha-adrenoceptor antagonists.
    Reid JL; Vincent J
    Cardiology; 1986; 73(3):164-74. PubMed ID: 2872958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and neuroendocrine responses to acute and chronic alpha-adrenergic blockade with prazosin and phenoxybenzamine.
    Mulvihill-Wilson J; Gaffney FA; Pettinger WA; Blomqvist CG; Anderson S; Graham RM
    Circulation; 1983 Feb; 67(2):383-93. PubMed ID: 6129077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in alpha-adrenergic receptor pharmacology: implications for the initial treatment of hypertension.
    Colucci WS
    Am J Cardiol; 1983 Feb; 51(4):639-43. PubMed ID: 6131604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic basis for the use of doxazosin in the treatment of essential hypertension.
    Davey MJ
    Am J Med; 1989 Aug; 87(2A):36S-44S. PubMed ID: 2569823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of alpha blockade for blood pressure control.
    Davey M
    Am J Cardiol; 1987 May; 59(14):18G-28G. PubMed ID: 2884849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circadian rise of blood pressure and combined alpha-beta adrenoceptor blockade].
    Rietbrock N; Woodcock BG
    Dtsch Med Wochenschr; 1985 Mar; 110(10):388-91. PubMed ID: 2857634
    [No Abstract]   [Full Text] [Related]  

  • 12. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral blockade of the sympathetic nervous system.
    Weber MA; Drayer JI
    Am J Med; 1984 Oct; 77(4A):110-8. PubMed ID: 6148889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of alpha-adrenoceptor blockade in the treatment of hypertension.
    Abrams SM; Turner P
    J Clin Hosp Pharm; 1983 Jun; 8(2):175-81. PubMed ID: 6135715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha 1-antagonists in the treatment of hypertension.
    Grimm RH
    Hypertension; 1989 May; 13(5 Suppl):I131-6. PubMed ID: 2577457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha- and beta-receptor blocking drugs in the treatment of hypertension.
    Ram CV; Kaplan NM
    Curr Probl Cardiol; 1979 Jan; 3(10):1-53. PubMed ID: 40755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 2-adrenergic receptors and calcium: alpha 2-receptor blockade in vascular smooth muscle as an approach to the treatment of hypertension.
    Lee JY; DeBernardis JF
    Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):213-25. PubMed ID: 1972206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.
    Good AP; Unverferth DV; Leier CV
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):529-34. PubMed ID: 2908715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
    Young RA; Brogden RN
    Drugs; 1988 May; 35(5):525-41. PubMed ID: 2899495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction.
    Taylor SH
    Am Heart J; 1988 Dec; 116(6 Pt 2):1735-47. PubMed ID: 2904744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.